With yearend closing price of $27.67 (remember, these charts are self updating) this is set up as an inverse head-and-shoulder pattern and clearly looking for a breakout to the upside, will be interesting to watch.
January 2016
|
01-05-2016, 12:09 AM
With yearend closing price of $27.67 (remember, these charts are self updating) this is set up as an inverse head-and-shoulder pattern and clearly looking for a breakout to the upside, will be interesting to watch.
01-05-2016, 12:11 AM
One of the Federal Reserve's hawkish officials said on Sunday that while she prefers a slightly more aggressive approach, she is not opposed to her colleagues' view that the U.S. central bank needs to raise interest rates only four times this year. Fed's Mester prefers a bit quicker U.S. rate-hike pace - Yahoo Finance Where do they find these people?? As if the dollar isn't strong enough already, oil still too high, emerging markets currencies not tumbling fast enough, industrial economies not struggling hard enough, the risk of a Chinese devaluation not big enough, inflation and wages are about to shoot higher, etc. etc.
01-05-2016, 12:21 AM
01-05-2016, 12:25 AM
From Zacks:
-6.2% for mid-caps Market is very short on breadth, held up by the likes of Amazon, Google, Microsoft, Facebook en Netflix.
01-05-2016, 12:27 AM
That JKS chart above, looks like a braking out below, rather than above is going to happen next, the stock is trading -10% pre-market
Our only purchase so far for 2016 (on 12/21 last year), Ellie Mae (ELLI) is holding up pretty well, at least for now on the support. At the moment it's even up a bit for the day at $60.30 while the markets are selling off 2%+
01-05-2016, 04:57 AM
While there is still two hours to go, the reversal in JKS is rather stunning. Opening at -10%, now just at -2%. Still, with Chinese markets down 7% and actually halted, I think we can't be blamed for not pulling the trigger here..
01-05-2016, 05:08 AM
This isn't going to yield instant results, but it's interesting nevertheless: U.S. Food and Drug Administration (FDA) seeking a reduced exposure order so that 22nd Centurys BRAND A Very Low Nicotine (VLN) cigarettes may be introduced into commerce in the United States. The application to the FDA requests that BRAND A packaging and marketing be allowed to disclose to consumers that the Companys proprietary Very Low Nicotine cigarettes reduce smokers exposure to nicotine. If successful, it will give these cigs a rather important marketing advantage in the US, where one isn't allowed to market with stuff like "light" or "low nicotine"..
01-06-2016, 12:02 AM
Interesting perspective from Zacks on the Chinese selloff:
01-06-2016, 01:06 AM
We have a new article out:
|
« Next Oldest | Next Newest »
|